THE AESTHETIC IMPACT OF MEDICATION-DRIVEN WEIGHT LOSS
BALANCING THE SCALES:
ADVANCING AESTHETICS IN THE ERA OF MEDICATION-DRIVEN WEIGHT LOSS TRANSFORMATIONS
The use of prescription weight loss medications has increased expontentially in recent years. Beyond reshaping weight loss, this trend is also giving rise to a new type of aesthetic patient.
As the pure-play dermatology category leader committed to medical education and training, Galderma set out to study the effects weight loss can have on the skin. The result was a groundbreaking report and pioneering guidelines that aim to equip healthcare professionals with the necessary tools and knowledge to help their patients achieve the radiant appearance they desire1,2.
UNDERSTANDING THE AESTHETIC IMPACTS OF SIGNIFICANT AND RAPID WEIGHT LOSS
THE GLOBAL RISE OF MEDICATION-DRIVEN WEIGHT LOSS
“Prescription weight loss medications are creating a new group of patients whose attitude towards health and their bodies has fundamentally changed. They feel more in control and able to take steps towards looking and feeling their best for the longest they can, including by using aesthetic solutions.”
Anne-Cecile chevrier
head of marketing for injectable aesthetics
galderma
REFERENCES
[1] Galderma MAC research. 2024
[2] Nikolis A, et al. Consensus Statements on Managing Aesthetic Needs in Prescription Medication-Driven Weight Loss Patients: An International, Multidisciplinary Delphi Study. JCD. 2025;24: e70094. https://doi.org/10.1111/jocd.70094
[3] KFF. KFF Health Tracking Poll May 2024: The Public’s Use and Views of GLP-1 Drugs. Available online. Accessed July 2025
[4] JP Morgan. The increase in appetite for obesity drugs. Available online. Accessed July 2025
[5] Market Insight. The semaglutide revolution study. October 2024
[6] Everyday Health. Ozempic shortage: how a weight loss fad has slashed access to a diabetes drug. Available online. Accessed July 2025
[7] Medical Insight. GLP-1 market & impact on the aesthetic provider. October 2024
[8] HAVAS. Prosumer report: welcome to the GLP-1 revolution. Available online. Accessed July 2025
[9] Humphrey CD & Lawrence AC. Implications of Ozempic and other GLP-1 receptor agonists for facial plastic surgeons. Facial Plast Surg. 2023;39:719-72. doi:10.1055/a-2148-6321